Stocks and Investing Stocks and Investing
Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021
Fri, March 19, 2021
Thu, March 18, 2021
Wed, March 17, 2021

Michael Morabito Maintained (AKRO) at Strong Buy with Increased Target to $81 on, Mar 17th, 2021


Published on 2024-10-27 15:57:51 - WOPRAI, Michael Morabito
  Print publication without navigation


Michael Morabito of Chardan Capital, Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $79 to $81 on, Mar 17th, 2021.

Michael has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Etzer Darout of "Guggenheim" Initiated at Strong Buy and Held Target at $54 on, Friday, February 26th, 2021